Ryan J. Watts, the President and CEO of $DNLI, sold 495,282 shares of the company on 07-09-2025 for an estimated $7,429,230. We received data on the trade from a recent SEC filing. This was a sale of approximately 66.2% of their shares of this class of stock. Following this trade, they now own 253,071 shares of this class of $DNLI stock.
$DNLI Insider Trading Activity
$DNLI insiders have traded $DNLI stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DNLI stock by insiders over the last 6 months:
- RYAN J. WATTS (President and CEO) sold 495,282 shares for an estimated $7,429,230
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DNLI Hedge Fund Activity
We have seen 105 institutional investors add shares of $DNLI stock to their portfolio, and 109 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,184,042 shares (+88.9%) to their portfolio in Q1 2025, for an estimated $43,287,050
- WELLINGTON MANAGEMENT GROUP LLP added 1,561,647 shares (+15.9%) to their portfolio in Q1 2025, for an estimated $21,230,590
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,308,619 shares (+42.8%) to their portfolio in Q1 2025, for an estimated $17,790,675
- MILLENNIUM MANAGEMENT LLC added 1,088,844 shares (+269.4%) to their portfolio in Q1 2025, for an estimated $14,802,834
- CAMBER CAPITAL MANAGEMENT LP removed 1,000,000 shares (-44.4%) from their portfolio in Q1 2025, for an estimated $13,595,000
- CAPITAL RESEARCH GLOBAL INVESTORS removed 712,074 shares (-13.0%) from their portfolio in Q1 2025, for an estimated $9,680,646
- SQUAREPOINT OPS LLC added 638,532 shares (+1313.3%) to their portfolio in Q1 2025, for an estimated $8,680,842
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DNLI Analyst Ratings
Wall Street analysts have issued reports on $DNLI in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 05/19/2025
- Baird issued a "Outperform" rating on 05/08/2025
- Wedbush issued a "Outperform" rating on 05/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/07/2025
- Morgan Stanley issued a "Overweight" rating on 03/07/2025
- B. Riley Securities issued a "Buy" rating on 03/05/2025
- Oppenheimer issued a "Outperform" rating on 03/03/2025
To track analyst ratings and price targets for $DNLI, check out Quiver Quantitative's $DNLI forecast page.
$DNLI Price Targets
Multiple analysts have issued price targets for $DNLI recently. We have seen 9 analysts offer price targets for $DNLI in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Tazeen Ahmad from B of A Securities set a target price of $27.0 on 05/19/2025
- Joel Beatty from Baird set a target price of $29.0 on 05/08/2025
- Laura Chico from Wedbush set a target price of $30.0 on 05/07/2025
- Andrew Fein from HC Wainwright & Co. set a target price of $32.0 on 05/07/2025
- Matthew Harrison from Morgan Stanley set a target price of $33.0 on 03/07/2025
- Mayank Mamtani from B. Riley Securities set a target price of $35.0 on 03/05/2025
- Jay Olson from Oppenheimer set a target price of $42.0 on 03/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
